Earum Pharmaceuticals announced its standalone and consolidated financials for the half year ended on March 31, 2020 marking rise in profit despite lower revenues.

Earum Pharmaceuticals earned standalone revenue of Rs.28.40 crore in the second half of FY2019-20 whereas in the preceding year same period it was Rs.28.98 crore.

Standalone net profit for the company reached Rs.96.13 lacs in HY2 of FY19-20 showing a rise when compared to Rs.26.44 lacs in a year ago period.

The standalone financials for the recently concluded year 2019-20 shows Earum Pharmaceuticals marking a PAT of Rs.1.81 crore with revenue of Rs.57.38 crore.

In the preceding year the companys revenue reached Rs.50.75 crore and PAT was Rs.1.66 crore.

Earnings per share in FY19-20 stands at Rs.2.94.

Recent Stories